1. Home
  2. UFPT vs ANAB Comparison

UFPT vs ANAB Comparison

Compare UFPT & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Technologies Inc.

UFPT

UFP Technologies Inc.

HOLD

Current Price

$223.77

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$60.44

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFPT
ANAB
Founded
1963
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
UFPT
ANAB
Price
$223.77
$60.44
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$289.00
$71.67
AVG Volume (30 Days)
197.0K
586.1K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
15.44
91.02
EPS
2.24
N/A
Revenue
$602,797,000.00
$234,603,000.00
Revenue This Year
$8.12
N/A
Revenue Next Year
$5.72
$52.14
P/E Ratio
$97.33
N/A
Revenue Growth
19.50
157.01
52 Week Low
$173.86
$17.11
52 Week High
$274.93
$73.30

Technical Indicators

Market Signals
Indicator
UFPT
ANAB
Relative Strength Index (RSI) 60.76 44.03
Support Level $211.11 $53.46
Resistance Level $232.68 $67.69
Average True Range (ATR) 14.79 4.38
MACD 0.81 -0.95
Stochastic Oscillator 78.43 17.33

Price Performance

Historical Comparison
UFPT
ANAB

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: